id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0453-0016,FDA,FDA-2005-N-0453,Skin Cancer Foundation to the Food and Drug Administration - Letter,Other,Letter(s),2008-08-19T04:00:00Z,2008,8,2008-08-19T04:00:00Z,,2019-07-05T19:37:20Z,,0,0,090000648063d6c7
FDA-2005-N-0453-0004,FDA,FDA-2005-N-0453,Time and Extent Application (TEA) Review for Bemotrizinol [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:00:12Z,,0,0,09000064804507cf
FDA-2005-N-0453-0005,FDA,FDA-2005-N-0453,Time and Extent Application (TEA) Review for Bisoctrizole [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:03:52Z,,0,0,09000064804507d0
FDA-2005-N-0453-0010,FDA,FDA-2005-N-0453,FDA Center for Drug Evaluation and Reseach (OTC) to Ciba Specialty Chemical Corporation Letter dated 10/31/2005 [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,BKG-Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:12:19Z,,0,0,09000064804507d8
FDA-2005-N-0453-0003,FDA,FDA-2005-N-0453,Ciba Specialty Chemicals Corporation - [Bemotrizinol] - Supplement,Other,Supplement (SUP),2008-06-13T04:00:00Z,2008,6,2008-06-13T04:00:00Z,,2013-05-07T21:31:57Z,,0,0,09000064804507e3
FDA-2005-N-0453-0013,FDA,FDA-2005-N-0453,Time and Extend Application Bemotrizinol [Product Labeling] [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:31:03Z,,0,0,09000064804507dc
FDA-2005-N-0453-0012,FDA,FDA-2005-N-0453,Time and Extend Application Bemotrizinol - [Appendices] [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:29:25Z,,0,0,09000064804507db
FDA-2005-N-0453-0009,FDA,FDA-2005-N-0453,Time and Extend Application Bisoctrizole [Product Labeling] [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:10:59Z,,0,0,09000064804507d7
FDA-2005-N-0453-0011,FDA,FDA-2005-N-0453,Time and Extend Application Bemotrizinol - [Prepared to support the Inclusion of Bemotrizinol  into FDA’s Monograph for Sunscreen Drug Products] [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:15:05Z,,0,0,09000064804507da
FDA-2005-N-0453-0007,FDA,FDA-2005-N-0453,Time and Extend Application Bisoctrizole - [Prepared to support the Inclusion of Bisoctrizole into FDA’s Monograph for Sunscreen Drug Products]  [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:06:46Z,,0,0,09000064804507d5
FDA-2005-N-0453-0008,FDA,FDA-2005-N-0453,Time and Extend Application Bisoctrizole - [Appendices] [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:09:09Z,,0,0,09000064804507d6
FDA-2005-N-0453-0002,FDA,FDA-2005-N-0453,Ciba Specialty Chemicals Corporation re Bisoctrizole - Supplement,Other,Supplement (SUP),2008-06-13T04:00:00Z,2008,6,2008-06-13T04:00:00Z,,2013-05-07T21:31:02Z,,0,0,09000064804507e2
FDA-2005-N-0453-0006,FDA,FDA-2005-N-0453,FDA Center for Drug Evaluation and Reseach (OTC) to Ciba Specialty Chemical Corporation Letter dated 10/31/2005 [FDA-2005-N-0453-0001] - Background,Supporting & Related Material,Background Material,2008-06-13T04:00:00Z,2008,6,,,2013-05-02T17:03:01Z,,0,0,09000064804507d3